Unit of Biostatistics and Research Methodology, Universiti Sains Malaysia, 16150 Kubang Kerian Kelantan, Kelantan, Malaysia.
Asian J Surg. 2010 Jul;33(3):127-33. doi: 10.1016/S1015-9584(10)60022-X.
To determine the 5-year survival rate and prognostic factors for survival in patients with colorectal cancer treated at the Surgical Unit, Hospital Universiti Sains Malaysia (HUSM), Kelantan, Malaysia.
We retrospectively reviewed the records of 115 patients treated in HUSM from 1996 to 2005. Data of variables considered as prognostic factors were obtained from the records. Simple and multiple Cox proportional hazard regression using the stepwise method were used to model the prognostic factors for survival.
We found that the significant prognostic factors were liver metastases [adjusted hazard ratio (HR): 3.75; 95% confidence interval (CI): 1.95-7.22], Dukes C stage (adjusted HR: 4.65; 95% CI: 2.37-9.11), Dukes D stage (adjusted HR: 6.71; 95% CI: 2.92-15.48) and non-surgical treatment (adjusted HR: 3.75; 95% CI: 1.26-11.21).
Colorectal patients treated at HUSM with Dukes C staging, presence of liver metastases and received treatment with both chemotherapy and radiotherapy are at the greatest risk of death from colorectal cancer.
确定在马来西亚大学科学医院(HUSM)外科病房接受治疗的结直肠癌患者的 5 年生存率和生存预后因素。
我们回顾性分析了 1996 年至 2005 年在 HUSM 接受治疗的 115 例患者的记录。从记录中获取被认为是预后因素的变量数据。使用逐步法的简单和多 Cox 比例风险回归来对生存的预后因素进行建模。
我们发现,显著的预后因素包括肝转移(调整后的风险比 [HR]:3.75;95%置信区间 [CI]:1.95-7.22)、 Dukes C 期(调整后的 HR:4.65;95% CI:2.37-9.11)、 Dukes D 期(调整后的 HR:6.71;95% CI:2.92-15.48)和非手术治疗(调整后的 HR:3.75;95% CI:1.26-11.21)。
在 HUSM 接受治疗的结直肠癌患者中,Dukes C 分期、存在肝转移且接受化疗和放疗联合治疗的患者,死于结直肠癌的风险最高。